Analytical Data
-
Gene name
COL1
- Application
-
Species
Horse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
XP_023508478.1
-
Expression Region
Arg1226~Phe1462
-
Molecular Weight
30kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Collagen type I (COL1) is the most abundant collagen in the human body, playing a crucial role in maintaining the structural integrity and mechanical properties of various tissues, including skin, bones, tendons, and ligaments. The study of COL1 recombinant proteins has gained significant attention in recent years due to their potential applications in regenerative medicine, tissue engineering, and biomaterials development. Advances in molecular cloning and recombinant DNA technology have enabled the production of COL1 in various expression systems, facilitating the study of its structural properties and biological functions. The ability to generate COL1 proteins allows for the investigation of their interactions with cells and other extracellular matrix components, contributing to our understanding of tissue repair and development. Moreover, recombinant COL1 can be engineered to possess specific properties, enhancing its usability in therapeutic contexts. Researchers are exploring its use in wound healing, bone regeneration, and even as a scaffold in 3D cell cultures and organoid development. Overall, the continued exploration of COL1 recombinant proteins holds promise for innovative treatments and the advancement of tissue engineering strategies.
